Allergy
-
Primary mast cell activation syndromes (MCAS) are a group of disorders presenting with symptoms of mast cell mediator release. ⋯ There is an urgent need for large, well-designed, double-blind, placebo-controlled randomized trials investigating the effectiveness, cost-effectiveness, and safety of second-generation H1 -antihistamines in treatment of primary MCAS.